$VNTA’s Gum Smacking Situation
January 4th, 2010 at 9:07 am Posted by The Dean
Back in July and August, The Dean taught the CollegeStock Community about Ventana Biotech’s (OTC: VNTA.PK ) appetite-suppressing and stress-fighting chewing gum and the profit potential of the company’s intellectual property.
In October, $VNTA announced that a U.S. company had contacted them to acquire its intellectual property (IP) but, at that point in time, $VNTA management stressed that negotiations were in their early stages.
About a month ago, $VNTA issued a follow-up release telling us the company was in the final stage of negotiations.
Now, here’s what The Dean’s getting at. Yesterday, $VNTA announced that the sale of its IP is still ongoing, due to an auditing issue expected to be “cleared up in January 2010.”
What makes this acquisition even better is that $VNTA told us that “the terms of the deal have already been agreed and it presents a value as per the date of the original offer and therefore a value significantly higher than what the current share price and market cap [are] reflecting.”
On Thursday, $VNTA closed at $0.075 but, since this deal was initially agreed upon in “early October,” The Dean believes the acquisition will purchase shares at a price which reflects that month.
The Dean has crunched some numbers and the average share price in “early October” was $0.321 per share. For the whole month of October, the average share price for $VNTA was $0.286. With those figures in mind, investors could gain 281% to 328% from current levels.
Certainly, The Dean wants all of his students to do their homework and make decisions based on calculated risk and their tolerance for potential losses.
